Australian Auto Stock News

ASX:ELS
ASX:ELSElectronic

How Elsight’s Boardroom Challenge and Q1 2026 Update Will Impact Elsight (ASX:ELS) Investors

Elsight Limited recently held its Q1 2026 earnings call on 29 April 2026, following news that shareholder activist Stephen Mayne had nominated himself for election as a non-executive director under Rule 14.3 of the company’s constitution, a move the board has urged investors to vote against at the 29 May 2026 AGM. This combination of an upcoming contested board vote and fresh quarterly results puts Elsight’s governance approach and execution under closer investor scrutiny. We’ll now examine...
ASX:EMR
ASX:EMRMetals and Mining

What Does Emerald Resources’ New COO Mean For Its Next Phase Of Execution (ASX:EMR)?

Emerald Resources recently reported strong half-year sales and net income and appointed Josh Redmond as Chief Operating Officer, marking a significant shift in its operational leadership structure. This combination of solid financial performance and an expanded executive bench is sharpening investor focus on how Emerald Resources executes its next phase of growth. We will now examine how Emerald Resources’ strengthened leadership team, highlighted by Josh Redmond’s appointment as COO,...
ASX:IPX
ASX:IPXMetals and Mining

IperionX (ASX:IPX) Is Up 10.3% After Moving To 24/7 Titanium Output And Insider Buying

IperionX recently shifted its Virginia facility to 24/7 continuous titanium production, advancing a government-backed push to build a domestic titanium supply chain for U.S. defense and industrial uses. This operational step, combined with fresh insider share purchases and long-dated equity awards, highlights management’s strong alignment with the company’s long-term titanium and critical minerals ambitions. We’ll now explore how the move to continuous titanium production shapes IperionX’s...
ASX:WOW
ASX:WOWConsumer Retailing

Woolworths Revises Earnings Outlook As Costs Challenge Q3 Sales Strength

Woolworths Group (ASX:WOW) has revised its earnings outlook following its Q3 trading update. Management cited material cost pressures, including inflation and fuel price impacts, as key factors influencing the new guidance. The company flagged increasing competitive and regulatory headwinds in Australia and New Zealand, particularly affecting its New Zealand operations. Woolworths also highlighted geopolitical risks as a source of ongoing uncertainty for future profitability. Woolworths...
ASX:APX
ASX:APXIT

Does Appen (ASX:APX) Holding Guidance Mask A Deeper Profitability Challenge In Its Core Business?

Appen recently reported a quarterly update showing around 9% revenue growth, driven by strong performance in its China segment, while its core Appen Global division continued to suffer from steep revenue declines and EBITDA losses. Despite the contrasting fortunes of China and Appen Global, management kept full-year guidance unchanged, which appears to have frustrated investors looking for clearer evidence of a sustained turnaround in group profitability. We’ll now examine how the guidance...
ASX:CYL
ASX:CYLMetals and Mining

Catalyst Metals (ASX:CYL) Is Down 17.0% After Hiking FY 2026 AISC Guidance – Has The Bull Case Changed?

Catalyst Metals recently released its quarterly update, reporting gold production of 26,127 ounces and reaffirming full-year output guidance of 100,000 to 110,000 ounces, while lifting its FY 2026 all-in sustaining cost guidance to A$2,750 to A$2,950 per ounce from A$2,200 to A$2,650. This sharp increase in expected per-ounce costs, despite steady production guidance, highlights growing margin pressure as a central issue for shareholders assessing the business. We will now examine how the...
ASX:MSB
ASX:MSBBiotechs

Is Completing Phase 3 Enrollment For Rexlemestrocel-L Reshaping The Investment Case For Mesoblast (ASX:MSB)?

In late April 2026, Mesoblast Limited reported it had completed patient recruitment for its pivotal 300-patient Phase 3 trial of rexlemestrocel-L in chronic low back pain due to degenerative disc disease, a placebo-controlled study designed around a 12-month pain reduction endpoint and supported by the therapy’s RMAT designation. This milestone moves rexlemestrocel-L closer to potential FDA submission for a condition affecting over 7 million Americans and heavily tied to opioid use,...
ASX:DRO
ASX:DROAerospace & Defense

A Look At DroneShield (ASX:DRO) Valuation As Defence Sector Interest Lifts The Stock

DroneShield (ASX:DRO) is back in focus after a sector wide lift in defence names, as governments increase spending on counter drone capabilities and the company heads into its Q1 2026 results and earnings call. See our latest analysis for DroneShield. DroneShield’s recent pullback, with a 30 day share price return of 9.3% and a 7 day decline of 3%, sits against a stronger 90 day share price return of 8.7% and a very large 1 year total shareholder return of 173.5%. This suggests longer term...
ASX:CDA
ASX:CDAElectronic

Codan (ASX:CDA) Is Up 21.6% After Surprising FY26 Earnings Upgrade And Margin Milestone Reached Early

Codan recently issued a major earnings upgrade and FY26 trading update, indicating FY26 EBIT is expected to be more than 60% higher than FY25 and that its Communications segment has reached a 30% profit margin target earlier than previously guided. This simultaneous outperformance in both defence-focused communications and Minelab’s metal detection products suggests Codan’s diversified technology portfolio is currently converting sector demand into higher-than-expected profitability. We’ll...
ASX:APA
ASX:APAGas Utilities

How Investors May Respond To APA Group (ASX:APA) Heavily Oversubscribed A$1.5 Billion Debt Raise

In April 2026, APA Group completed a A$1.50 billion debt raise, including A$1.00 billion in hybrid subordinated capital securities and A$500 million in 6.42% senior unsecured notes due 2036, to support its stated growth plans. The strong investor demand for these fixed-income securities, with the issuances reportedly nearly four times oversubscribed, underlines fixed-income appetite for APA’s income-focused infrastructure profile. Now we’ll consider how this heavily oversubscribed A$1.50...
ASX:SUN
ASX:SUNInsurance

Does Suncorp’s Hybrid Note Issue Signal a Strategic Shift in Its Capital Mix (ASX:SUN)?

Suncorp Group Limited recently completed a Fixed-Income Offering, issuing A$200 million of Floating Rate Hybrid Notes that are convertible, non-cumulative and subordinated, with a variable coupon structure. This hybrid issuance adds a new layer to Suncorp’s capital structure, blending debt and equity characteristics that may influence how investors assess its funding mix and risk profile. We’ll now examine how Suncorp’s use of subordinated, floating rate hybrid capital could reshape its...
ASX:GGP
ASX:GGPMetals and Mining

A Look At Greatland Resources’ (ASX:GGP) Valuation After Its Strong Year To Date Share Price Return

Recent share performance and fundamentals Greatland Resources (ASX:GGP) has drawn attention after a recent uptick in share price over the past month, alongside a year to date return above 25%, prompting investors to reassess the A$9.1b miner. The company reports revenue of A$1,918.1m and net income of A$645.1m, with revenue growth of 4.7% and net income movement showing a 5.0% decline on an annual basis. See our latest analysis for Greatland Resources. At a latest share price of A$13.5,...
ASX:TLX
ASX:TLXBiotechs

Does New TLX597-Tx Data And Pipeline Progression Change The Bull Case For Telix (ASX:TLX)?

In late April 2026, Telix Pharmaceuticals reported Phase 2 OPTIMAL-PSMA dosimetry data for its second-generation prostate cancer candidate TLX597-Tx, showing low radiation uptake in non-target organs and supporting further evaluation in earlier-stage disease, while also progressing a Regeneron collaboration and a European review of its glioma imaging agent TLX101-Px. These developments highlight how Telix is trying to build an integrated radiopharmaceutical platform, pairing next-generation...
ASX:COH
ASX:COHMedical Equipment

How Cochlear’s FY26 Profit Downgrade At Cochlear (ASX:COH) Has Changed Its Investment Story

Cochlear Limited recently downgraded its FY26 net profit guidance from A$435–A$460 million to A$290–A$330 million, citing softer demand, delayed surgeries, and geopolitical disruptions in key markets. This setback has drawn attention to how dependent Cochlear’s earnings are on procedure volumes and hospital capacity, despite its strong competitive position in implantable hearing solutions. We’ll now examine how this earnings guidance cut, driven by weaker demand and delayed surgeries, may...
ASX:NIC
ASX:NICMetals and Mining

Nickel Industries (ASX:NIC) Is Up 7.0% After Record EBITDA And Excelsior Progress Is The Bull Case Changed?

In late April 2026, Nickel Industries Limited reported its March quarter results, delivering record adjusted EBITDA of US$135.6 million, supported by a higher Indonesian production quota, accelerated ore sales, and progress on the Excelsior Nickel Cobalt project. Alongside this financial performance, the company highlighted a lost time injury frequency rate of 0.00, expanded conservation efforts over about 197 hectares of primary forest at Hengjaya, and a stronger liquidity position through...
ASX:RMS
ASX:RMSMetals and Mining

Ramelius Resources (ASX:RMS) Is Down 8.6% After Record Quarterly Profitability Amid Rising Diesel Costs – Has The Bull Case Changed?

On 29 April 2026, Ramelius Resources reported its most profitable quarter to date, delivering a very large all-in sustaining cost margin despite revising cost guidance higher due partly to accounting changes and stronger gold prices. At the same time, the company accelerated its share buyback and advanced high‑grade discoveries at Dalgaranga, underlining management’s conviction in the business while industry‑wide diesel cost pressures continued to reshape its operating cost base. We’ll now...
ASX:EVN
ASX:EVNMetals and Mining

A Look At Evolution Mining’s Valuation After Its Latest Resource Upgrade

Evolution Mining (ASX:EVN) has reported a significant uplift in its gold and copper resources, linked to recent exploration results and ongoing expansion studies. This has drawn fresh attention to the miner’s long term production profile. See our latest analysis for Evolution Mining. Despite the fresh resource update, Evolution Mining’s recent share price momentum has cooled, with a 30 day share price return of a 10.99% decline and a 90 day share price return of a 17.40% decline. This comes...
ASX:NXT
ASX:NXTIT

Should NEXTDC’s A$2.26B Capital Raise and A$6.6B Liquidity Shift Matter to (ASX:NXT) Investors?

NEXTDC Limited recently completed a large-scale capital raising, including an A$750 million subordinated floating rate wholesale notes issue and an approximately A$1.51 billion rights-based follow-on equity offering, as part of its previously announced A$2.20 billion capital plan. These transactions lift NEXTDC’s pro forma liquidity to about A$6.60 billion and broaden its funding base as it pursues growth in Australia’s expanding data centre market. We’ll now examine how this expanded A$6.60...
ASX:ARU
ASX:ARUMetals and Mining

Assessing Arafura Rare Earths’ Valuation Ahead Of The Q3 2026 Earnings Call

Why Arafura Rare Earths’ Upcoming Earnings Call Matters Arafura Rare Earths (ASX:ARU) is set to hold its Q3 2026 earnings call on 29 April. Many investors are watching the event closely for fresh detail on project progress, funding, and outlook. See our latest analysis for Arafura Rare Earths. At a share price of A$0.36, Arafura Rare Earths has seen strong recent momentum, with a 30 day share price return of 18.03%, a 90 day share price return of 56.52%, and a 1 year total shareholder return...
ASX:AMI
ASX:AMIMetals and Mining

A Look At Aurelia Metals (ASX:AMI) Valuation After The Return Of Lyn Brazil To The Board

Board refresh draws fresh attention to Aurelia Metals Aurelia Metals (ASX:AMI) has attracted fresh interest after announcing that Franklyn (Lyn) Brazil will rejoin its Board as a Non Executive Director, representing Brazil Farming Pty Ltd. Brazil brings prior Aurelia board experience, a background in agriculture and philanthropy, and a history of investing in ASX listed companies. Accounting and markets professional Bradley Newcombe will act as his alternate director. See our latest analysis...